These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10945864)

  • 81. Chloroquine accumulation in isolated rat liver lysosomes.
    Reijngoud DJ; Tager JM
    FEBS Lett; 1976 Apr; 64(1):231-5. PubMed ID: 5310
    [No Abstract]   [Full Text] [Related]  

  • 82. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts.
    Hollemans M; Elferink RO; De Groot PG; Strijland A; Tager JM
    Biochim Biophys Acta; 1981 Apr; 643(1):140-51. PubMed ID: 7236683
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages.
    Ufuk A; Assmus F; Francis L; Plumb J; Damian V; Gertz M; Houston JB; Galetin A
    Mol Pharm; 2017 Apr; 14(4):1033-1046. PubMed ID: 28252969
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Spectrophotometric study of the physico-chemical properties of lysosomes isolated from rat liver].
    Frolov VA; Siatkin SP
    Vopr Med Khim; 1990; 36(6):36-9. PubMed ID: 2075720
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Uptake in vitro of lipophilic model compounds into adipose tissue preparations and lipids.
    Di Francesco C; Bickel MH
    Biochem Pharmacol; 1985 Oct; 34(20):3683-8. PubMed ID: 3931649
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
    Schmitt MV; Lienau P; Fricker G; Reichel A
    Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [pH dynamics in the lysosomes and cytoplasm of tissue culture cells measured intravitally using the indicator dye neutral red].
    Litinskaia LL; Ogloblina TA; Veksler AM; Agroskin LS; Papaian GV
    Tsitologiia; 1982 Oct; 24(10):1215-22. PubMed ID: 7179473
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Measurement of intralysosomal pH.
    Riejngoud DJ; Tager JM
    Biochim Biophys Acta; 1973 Jan; 297(1):174-8. PubMed ID: 4693517
    [No Abstract]   [Full Text] [Related]  

  • 89. Binding of drugs to muscle tissue: dependence on drug concentration and lipid content of tissue.
    Fichtl B; Bondy B; Kurz H
    J Pharmacol Exp Ther; 1980 Oct; 215(1):248-53. PubMed ID: 7452487
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Growth inhibition of 3T3 fibroblasts by lysosomotropic amines: correlation with effects on intravesicular pH but not vacuolation.
    Cain CC; Murphy RF
    J Cell Physiol; 1986 Oct; 129(1):65-70. PubMed ID: 3760033
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
    Logan R; Funk RS; Axcell E; Krise JP
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages.
    Poole B; Ohkuma S
    J Cell Biol; 1981 Sep; 90(3):665-9. PubMed ID: 6169733
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Acidic pH and the hepatic detoxification of endotoxin.
    Filkins JP
    J Reticuloendothel Soc; 1973 Jun; 13(6):511-7. PubMed ID: 4577222
    [No Abstract]   [Full Text] [Related]  

  • 94. Intrahepatic disposition of xenobiotics in relation with their partition coefficient.
    Ong H; du Souich P; Marchand C
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):237-58. PubMed ID: 7071413
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
    Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
    Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
    Schneider P; Korolenko TA; Busch U
    Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The acidification of rat liver lysosomes in vitro: a role for the membranous ATPase as a proton pump.
    Schneider DL
    Biochem Biophys Res Commun; 1979 Mar; 87(2):559-65. PubMed ID: 87191
    [No Abstract]   [Full Text] [Related]  

  • 98. Is the ATP-dependent protection of lysosomes against osmotic lysis a function of the lysosomal proton pump.
    Ruth RC; Weglicki WB
    Mol Cell Biochem; 1989 Oct; 90(2):165-73. PubMed ID: 2586496
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prediction of V(ss) from in vitro tissue-binding studies.
    Berry LM; Roberts J; Be X; Zhao Z; Lin MH
    Drug Metab Dispos; 2010 Jan; 38(1):115-21. PubMed ID: 19797608
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Differences in adipose tissue distribution of basic lipophilic drugs between intraperitoneal and other routes of administration.
    Betschart HR; Jondorf WR; Bickel MH
    Xenobiotica; 1988 Jan; 18(1):113-21. PubMed ID: 3354228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.